These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36746747)

  • 21. Robotic stereotactic ablative radiotherapy for renal cell carcinoma in patients with impaired renal function.
    Senger C; Conti A; Kluge A; Pasemann D; Kufeld M; Acker G; Lukas M; Grün A; Kalinauskaite G; Budach V; Waiser J; Stromberger C
    BMC Urol; 2019 Oct; 19(1):96. PubMed ID: 31638979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases.
    Kothari G; Louie AV; Pryor D; Vela I; Lo SS; Teh BS; Siva S
    Chin Clin Oncol; 2017 Sep; 6(Suppl 2):S17. PubMed ID: 28917255
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation Therapy for Patients with Advanced Renal Cell Carcinoma.
    Miccio JA; Oladeru OT; Jun Ma S; Johung KL
    Urol Clin North Am; 2020 Aug; 47(3):399-411. PubMed ID: 32600541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Radiation in Treatment of Renal Cell Carcinoma.
    Leeman JE
    Hematol Oncol Clin North Am; 2023 Oct; 37(5):921-924. PubMed ID: 37246085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Reintroduction of Radiotherapy Into the Integrated Management of Kidney Cancer.
    Dohopolski M; Hannan R; Wardak Z; Hammers H; Garant A
    Cancer J; 2020; 26(5):448-459. PubMed ID: 32947313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK).
    Siva S; Louie AV; Warner A; Muacevic A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh B; Correa RJ; Lo SS; Staehler M
    Cancer; 2018 Mar; 124(5):934-942. PubMed ID: 29266183
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic Radiotherapy as a Treatment Option for Renal Tumors in the Solitary Kidney: A Multicenter Analysis from the IROCK.
    Correa RJM; Louie AV; Staehler M; Warner A; Gandhidasan S; Ponsky L; Ellis R; Kaplan I; Mahadevan A; Chu W; Swaminath A; Onishi H; Teh BS; Lo SS; Muacevic A; Siva S
    J Urol; 2019 Jun; 201(6):1097-1104. PubMed ID: 30741849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic body radiation therapy for metastases to the kidney in patients with non-small cell lung cancer: a new treatment paradigm for durable palliation.
    Verma V; Simone CB
    Ann Palliat Med; 2017 Apr; 6(2):96-103. PubMed ID: 28480719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial.
    Hoegen P; Zhang KS; Tonndorf-Martini E; Weykamp F; Regnery S; Naumann P; Lang K; Ristau J; Körber SA; Dreher C; Buchele C; Rippke C; Renkamp CK; Paul KM; König L; Büsch C; Krisam J; Sedlaczek O; Schlemmer HP; Niyazi M; Corradini S; Debus J; Klüter S; Hörner-Rieber J
    Radiat Oncol; 2022 Mar; 17(1):59. PubMed ID: 35346270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic body radiation therapy (SBRT) on renal cell carcinoma, an overview of technical aspects, biological rationale and current literature.
    Francolini G; Detti B; Ingrosso G; Desideri I; Becherini C; Carta G; Pezzulla D; Caramia G; Dominici L; Maragna V; Teriaca MA; Bottero M; Livi L
    Crit Rev Oncol Hematol; 2018 Nov; 131():24-29. PubMed ID: 30293702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SBRT in Localized Renal Carcinoma: A Review of the Literature.
    DE LA Pinta C; Latorre RG; Fuentes R
    Anticancer Res; 2022 Feb; 42(2):667-674. PubMed ID: 35093865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT).
    Folkert MR; Timmerman RD
    Adv Drug Deliv Rev; 2017 Jan; 109():3-14. PubMed ID: 27932046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment Outcomes of Stereotactic Body Radiotherapy in Patients with Synchronous and Metachronous Oligometastatic Renal Cell Carcinoma.
    Guler OC; Oymak E; Hurmuz P; Yavas G; Tilki B; Yavas C; Ozyigit G; Onal C
    Urol Int; 2023; 107(2):171-178. PubMed ID: 36455527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
    Marvaso G; Jereczek-Fossa BA; Zaffaroni M; Vincini MG; Corrao G; Andratschke N; Balagamwala EH; Bedke J; Blanck O; Capitanio U; Correa RJM; De Meerleer G; Franzese C; Gaeta A; Gandini S; Garibaldi C; Gerszten PC; Gillessen S; Grubb WR; Guckenberger M; Hannan R; Jhaveri PM; Josipovic M; Kerkmeijer LGW; Lehrer EJ; Lindskog M; Louie AV; Nguyen QN; Ost P; Palma DA; Procopio G; Rossi M; Staehler M; Tree AC; Tsang YM; Van As N; Zaorsky NG; Zilli T; Pasquier D; Siva S
    Lancet Oncol; 2024 May; 25(5):e193-e204. PubMed ID: 38697165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Landscape of Stereotactic Ablative Radiotherapy (SABR) for Renal Cell Cancer (RCC).
    Moreno-Olmedo E; Sabharwal A; Das P; Dallas N; Ford D; Perna C; Camilleri P
    Cancers (Basel); 2024 Jul; 16(15):. PubMed ID: 39123406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Emerging Role of Extracranial Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma: A Systematic Review.
    Le Guevelou J; Sargos P; Siva S; Ploussard G; Ost P; Gillessen S; Zilli T
    Eur Urol Focus; 2023 Jan; 9(1):114-124. PubMed ID: 36151031
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Durable control of locally recurrent renal cell carcinoma using stereotactic body radiotherapy.
    Maclean J; Breau RH; Scheida N; Malone S
    BMJ Case Rep; 2014 Sep; 2014():. PubMed ID: 25199199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stereotactic Body Radiotherapy for Localized Kidney Cancer.
    Rich BJ; Noy MA; Dal Pra A
    Curr Urol Rep; 2022 Dec; 23(12):371-381. PubMed ID: 36383304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stereotactic ablative radiation therapy in renal cell carcinoma: From oligometastatic to localized disease.
    Alongi F; Arcangeli S; Triggiani L; Mazzola R; Buglione di Monale E Bastia M; Fersino S; Baiguini A; Jereczek-Fossa BA; Magrini SM;
    Crit Rev Oncol Hematol; 2017 Sep; 117():48-56. PubMed ID: 28807235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost Effectiveness Analysis of Radiofrequency Ablation (RFA) Versus Stereotactic Body Radiotherapy (SBRT) for Early Stage Renal Cell Carcinoma (RCC).
    Donovan EK; Xie F; Louie AV; Chu W; Siva S; Kapoor A; Swaminath A
    Clin Genitourin Cancer; 2022 Oct; 20(5):e353-e361. PubMed ID: 35490099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.